Our goal at CurvyQ is to facilitate effective and appropriate care for women seeking a breast health-related diagnosis to reduce stress and costs.

Finding a lump in your breast can be a terrifying experience. Every year, millions of young women will seek care for such a lump and will likely undergo many tests, many of which may be unnecessary. Young women are at an especially low risk of breast cancer and have the greatest frequency of benign breast diseases (which are rarely harmful) yet millions of painful, costly, and time-consuming tests are ordered every year "just in case" for lack of a better option.

Even for noninvasive cancers, there are an estimated $35 million in unnecessary tests every year. [1]

Using low-cost, simple technology, we are working on a tool to be that better option and help provide piece of mind. 

The median age of diagnosis of a benign breast disease is 22 years old, whereas the median age of newly diagnosed cancers is 62. 

The median age of diagnosis of a benign breast disease is 22 years old, whereas the median age of newly diagnosed cancers is 62. 

  1.  Christopher J. VandenBussche, Ashley Cimino-Mathews, Ben Ho Park, Leisha A. Emens, Theodore N. Tsangaris, Pedram Argani. Reflex Estrogen Receptor (ER) and Progesterone Receptor (PR) Analysis of Ductal Carcinoma In Situ (DCIS) in Breast Needle Core Biopsy SpecimensThe American Journal of Surgical Pathology, 2016; 40 (8): 1090 DOI: 10.1097/PAS.0000000000000674